{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:58:40Z","timestamp":1761746320993,"version":"build-2065373602"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundo de Incentivo \u00e0 Pesquisa"},{"name":"Programa de Apoio a N\u00facleos de Excel\u00eancia\/Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento. Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["408344\/2021-0"],"award-info":[{"award-number":["408344\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Brazilian Research Council","award":["308338\/2020-0"],"award-info":[{"award-number":["308338\/2020-0"]}]},{"name":"funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","award":["2021\/02752-6"],"award-info":[{"award-number":["2021\/02752-6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04431-4","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:18:11Z","timestamp":1759209491000},"page":"1008-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimal timing of early thyroidectomy in young patients with MEN2A and its impact on disease outcome"],"prefix":"10.1007","volume":"90","author":[{"given":"Laura","family":"Marmitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via Oliveira Facuri","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleber Pinto","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Amaro","family":"da Silveira Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Chow","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Borsatto","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Ferreira","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Monteiro","family":"de Barros Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"9","key":"4431_CR1","doi-asserted-by":"publisher","first-page":"R499","DOI":"10.1530\/ERC-18-0574","volume":"26","author":"L Ceolin","year":"2019","unstructured":"L. Ceolin, M.A.D.S. Duval, A.F. Benini, C.V. Ferreira, A.L. Maia, Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. Endocr. Relat. Cancer. 26(9), R499\u2013R518 (2019). https:\/\/doi.org\/10.1530\/ERC-18-0574","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"4431_CR2","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1210\/jc.2013-1204","volume":"98","author":"SA Wells Jr","year":"2013","unstructured":"S.A. Jr Wells, F. Pacini, B.G. Robinson, M. Santoro, Multiple endocrine neoplasia type 2 and Familial medullary thyroid carcinoma: an update. J. Clin. Endocrinol. Metab. 98(8), 3149\u20133164 (2013). https:\/\/doi.org\/10.1210\/jc.2013-1204","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"4431_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nrendo.2011.139","volume":"7","author":"SG Waguespack","year":"2011","unstructured":"S.G. Waguespack, T.A. Rich, N.D. Perrier, C. Jimenez, G.J. Cote, Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat. Rev. Endocrinol. 7(10), 596\u2013607 (2011). Published 2011 Aug 23. https:\/\/doi.org\/10.1038\/nrendo.2011.139","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"4431_CR4","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1210\/clinem\/dgae133","volume":"109","author":"SG Hensley","year":"2024","unstructured":"S.G. Hensley, M.I. Hu, R.L. Bassett, A.K. Ying, M.E. Zafereo, N.D. Perrier, N.L. Busaidy, S.M. Hyde, E.G. Grubbs, S.G. Waguespack, Pediatric medullary thyroid carcinoma: clinical presentations and Long-Term outcomes in 144 patients over 6 decades. J. Clin. Endocrinol. Metab. 109(9), 2256\u20132268 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgae133","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4431_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W.W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H.L. Rehm, ACMG Laboratory Quality Assurance Committee, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17(5), 405\u2013424 (2015). https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet. Med."},{"key":"4431_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","volume":"79","author":"JS Mathiesen","year":"2022","unstructured":"J.S. Mathiesen, G. Effraimidis, M. Rossing, \u00c5.K. Rasmussen, L. Hoejberg, L. Bastholt, C. Godballe, P. Oturai, U. Feldt-Rasmussen, Multiple endocrine neoplasia type 2: A review. Semin Cancer Biol. 79, 163\u2013179 (2022). https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.035","journal-title":"Semin Cancer Biol."},{"issue":"6","key":"4431_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"S.A. Jr Wells, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack, American thyroid association guidelines task force on medullary thyroid carcinoma. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid. 25(6), 567\u2013610 (2015). https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"issue":"7","key":"4431_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1590\/0004-2730000003427","volume":"58","author":"AL Maia","year":"2014","unstructured":"A.L. Maia, D.R. Siqueira, M.A. Kulcsar, A.J. Tincani, G.M. Mazeto, L.M. Maciel, Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the thyroid department of the Brazilian society of endocrinology and metabolism. Arq. Bras. Endocrinol. Metabol. 58(7), 667\u2013700 (2014). English, Portuguese. https:\/\/doi.org\/10.1590\/0004-2730000003427","journal-title":"Arq. Bras. Endocrinol. Metabol"},{"issue":"4","key":"4431_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000346174","volume":"1","author":"R Elisei","year":"2013","unstructured":"R. Elisei, M. Alevizaki, B. Conte-Devolx, K. Frank-Raue, V. Leite, G.R. Williams, 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. Eur Thyroid J. 1(4), 216\u2009\u2013\u200931 (2013). https:\/\/doi.org\/10.1159\/000346174","journal-title":"Eur Thyroid J."},{"issue":"19","key":"4431_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"C. Eng, D. Clayton, I. Schuffenecker, G. Lenoir, G. Cote, R.F. Gagel, H.K. van Amstel, C.J. Lips, I. Nishisho, S.I. Takai, D.J. Marsh, B.G. Robinson, K. Frank-Raue, F. Raue, F. Xue, W.W. Noll, C. Romei, F. Pacini, M. Fink, B. Niederle, J. Zedenius, M. Nordenskj\u00f6ld, P. Komminoth, G.N. Hendy, L.M. Mulligan et al., The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276(19), 1575\u20131579 (1996)","journal-title":"JAMA"},{"issue":"3","key":"4431_CR11","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1210\/jcem.86.3.7290","volume":"86","author":"A Machens","year":"2001","unstructured":"A. Machens, O. Gimm, R. Hinze, W. H\u00f6ppner, B.O. Boehm, H. Dralle, Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J. Clin. Endocrinol. Metab. 86(3), 1104\u20131109 (2001). https:\/\/doi.org\/10.1210\/jcem.86.3.7290","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4431_CR12","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1210\/jc.2002-021422","volume":"88","author":"MK Pu\u00f1ales","year":"2003","unstructured":"M.K. Pu\u00f1ales, H. Graf, J.L. Gross, A.L. Maia, RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome. J. Clin. Endocrinol. Metab. 88(6), 2644\u20132649 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021422","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4431_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1530\/EC-18-0506","volume":"8","author":"RMB Maciel","year":"2019","unstructured":"R.M.B. Maciel, C.P. Camacho, L.V.M. Assump\u00e7\u00e3o, N.E. Bufalo, A.L. Carvalho, de G.A. Carvalho, L.A. Castroneves, de F.M. Castro, L. Ceolin, J.M. Cerutti, R. Corbo, T.M.B.L. Ferraz, C.V. Ferreira, M.I.C. Fran\u00e7a, H.C.R. Galv\u00e3o, F. Germano-Neto, H. Graf, A.A.L. Jorge, I.S. Kunii, M.W. Lauria, V.L.G. Leal, S.C. Lindsey, D.M. Louren\u00e7o, L.M.Z. Maciel, P.K.R. Magalh\u00e3es, J.R.M. Martins, M.C. Martins-Costa, G.M.F.S. Mazeto, A.I. Impellizzeri, C.R. Nogueira, E.I. Palmero, C.H.C.N. Pessoa, B. Prada, D.R. Siqueira, M.S.A. Sousa, R.A. Toledo, F.O.F. Valente, F. Vaisman, L.S. Ward, S.S. Weber, R.V. Weiss, J.H. Yang, M.R. Dias-da-Silva, A.O. Hoff, S.P.A. Toledo, A.L. Maia, Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the brasmen study. Endocr. Connect. 8(3), 289\u2013298 (2019). https:\/\/doi.org\/10.1530\/EC-18-0506","journal-title":"Endocr. Connect."},{"issue":"2","key":"4431_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10689-016-9948-7","volume":"16","author":"KL Long","year":"2017","unstructured":"K.L. Long, C. Etzel, T. Rich, S. Hyde, N.D. Perrier, P.H. Graham, J.E. Lee, M.I. Hu, G.J. Cote, R. Gagel, E.G. Grubbs, All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer. 16(2), 283\u2013289 (2017). https:\/\/doi.org\/10.1007\/s10689-016-9948-7","journal-title":"Fam Cancer"},{"key":"4431_CR15","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/cncr.22244","volume":"107","author":"S Roman","year":"2006","unstructured":"S. Roman, R. Lin, J.A. Sosa, Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 107, 2134\u20132142 (2006). https:\/\/doi.org\/10.1002\/cncr.22244","journal-title":"Cancer"},{"key":"4431_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.oraloncology.2018.06.002","volume":"83","author":"Z Al-Qurayshi","year":"2018","unstructured":"Z. Al-Qurayshi, H. Khadra, K. Chang, N. Pagedar, G.W. Randolph, E. Kandil, Risk and survival of patients with medullary thyroid cancer: National perspective. Oral Oncol. 83, 59\u201363 (2018). https:\/\/doi.org\/10.1016\/j.oraloncology.2018.06.002","journal-title":"Oral Oncol."},{"key":"4431_CR17","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1210\/jc.2015-1689","volume":"100","author":"A Machens","year":"2015","unstructured":"A. Machens, D. Henning, Therapeutic effectiveness of screening for multiple endocrine neoplasia type 2A. J. Clin. Endocrinol. Metab. 100, 2539\u20132545 (2015). https:\/\/doi.org\/10.1210\/jc.2015-1689","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"29","key":"4431_CR18","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1097\/MD.0000000000001108","volume":"94","author":"WP Kluijfhout","year":"2015","unstructured":"W.P. Kluijfhout, van D.J. Beek, A.A. Verrijn Stuart, L. Lodewijk, G.D. Valk, van der D.C. Zee, M.R. Vriens, I.H.M. Borel Rinkes, Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2: retrospective cohort analysis. Med. (Baltim). 94(29), e1108 (2015). https:\/\/doi.org\/10.1097\/MD.0000000000001108","journal-title":"Med. (Baltim)."},{"issue":"2","key":"4431_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1210\/jc.2011-2046","volume":"97","author":"R Elisei","year":"2012","unstructured":"R. Elisei, C. Romei, G. Renzini, V. Bottici, B. Cosci, E. Molinaro, L. Agate, V. Cappagli, P. Miccoli, P. Berti, P. Faviana, C. Ugolini, F. Basolo, P. Vitti, A. Pinchera, The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J. Clin. Endocrinol. Metab. 97(2), 426\u2013435 (2012). https:\/\/doi.org\/10.1210\/jc.2011-2046","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4431_CR20","doi-asserted-by":"publisher","first-page":"E509","DOI":"10.1210\/jc.2010-1234","volume":"96","author":"V Rohmer","year":"2011","unstructured":"V. Rohmer, G. Vidal-Trecan, A. Bourdelot, P. Niccoli, A. Murat, J.L. Wemeau, F. Borson-Chazot, C. Schvartz, A. Tabarin, O. Chabre, G. Chabrier, P. Caron, P. Rodien, M. Schlumberger, E. Baudin, Groupe Fran\u00e7ais des tumeurs endocrines. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the groupe Francais d\u2019etude des tumeurs endocrines. J. Clin. Endocrinol. Metab. 96(3), E509\u2013E518 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1234","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"4431_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1089\/thy.2015.0673","volume":"26","author":"EM Opsahl","year":"2016","unstructured":"E.M. Opsahl, M. Brauckhoff, E. Schlichting, K. Helset, J. Svartberg, K. Brauckhoff, L. M\u00e6hle, L.F. Engebretsen, E. Sigstad, K.K. Gr\u00f8holt, L.A. Akslen, L.H. J\u00f8rgensen, J.E. Varhaug, T. Bj\u00f8ro, A nationwide study of multiple endocrine neoplasia type 2A in norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma. Thyroid. 26(9), 1225\u20131238 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0673","journal-title":"Thyroid"},{"issue":"4","key":"4431_CR22","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1210\/jc.2004-1836","volume":"90","author":"A Machens","year":"2005","unstructured":"A. Machens, U. Schneyer, H.J. Holzhausen, H. Dralle, Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J. Clin. Endocrinol. Metab. 90(4), 2029\u20132034 (2005). https:\/\/doi.org\/10.1210\/jc.2004-1836","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"21","key":"4431_CR23","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.3390\/cancers13215554","volume":"13","author":"A Prete","year":"2021","unstructured":"A. Prete, A. Matrone, C. Gambale, V. Bottici, V. Cappagli, C. Romei, L. Torregrossa, L. Valerio, E. Minaldi, M.C. Campopiano, L. Lorusso, L. Agate, E. Molinaro, D. Viola, T. Ramone, C. Mul\u00e8, R. Ciampi, F. Basolo, R. Elisei, Active surveillance in RET gene carriers belonging to families with multiple endocrine neoplasia. Cancers (Basel). 13(21), 5554 (2021). https:\/\/doi.org\/10.3390\/cancers13215554","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4431_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12672-012-0109-7","volume":"3","author":"SC Lindsey","year":"2012","unstructured":"S.C. Lindsey, I.S. Kunii, F. Germano-Neto, M.Y. Sittoni, C.P. Camacho, F.O. Valente, J.H. Yang, P.S. Signorini, R. Delcelo, J.M. Cerutti, R.M. Maciel, M.R. Dias-da-Silva, Extended RET gene analysis in patients with apparently sporadic medullary thyroid cancer: clinical benefits and cost. Horm. Cancer. 3(4), 181\u2013186 (2012). https:\/\/doi.org\/10.1007\/s12672-012-0109-7","journal-title":"Horm. Cancer"},{"issue":"2","key":"4431_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000363055","volume":"3","author":"CP Camacho","year":"2014","unstructured":"C.P. Camacho, S.C. Lindsey, T.S. Kasamatsu, A.L. Machado, J.R. Martins, R.P. Biscolla, M.R. Dias da Silva, J.G. Vieira, R.M. Maciel, Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases. Eur. Thyroid J. 3(2), 117\u2013124 (2014). https:\/\/doi.org\/10.1159\/000363055","journal-title":"Eur. Thyroid J."},{"key":"4431_CR26","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"A. Machens, H. Dralle, Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J. Clin. Endocrinol. Metab. 95, 2655\u20132663 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2368","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"4431_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/thy.2019.0785","volume":"30","author":"MB Niederle","year":"2020","unstructured":"M.B. Niederle, C. Scheuba, P. Riss, A. Selberherr, O. Koperek, B. Niederle, Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays?? Thyroid. 30(7), 974\u2013984 (2020). https:\/\/doi.org\/10.1089\/thy.2019.0785","journal-title":"Thyroid"},{"issue":"8","key":"4431_CR28","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1210\/jc.2008-0660","volume":"93","author":"JA Sosa","year":"2008","unstructured":"J.A. Sosa, C.T. Tuggle, T.S. Wang, D.C. Thomas, L. Boudourakis, S. Rivkees, S.A. Roman, Clinical and economic outcomes of thyroid and parathyroid surgery in children. J. Clin. Endocrinol. Metab. 93(8), 3058\u20133065 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0660","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4431_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00268-003-6903-1","volume":"28","author":"L Rosato","year":"2004","unstructured":"L. Rosato, N. Avenia, P. Bernante, De M. Palma, G. Gulino, P.G. Nasi, M.R. Pelizzo, L. Pezzullo, Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J. Surg. 28(3), 271\u2013276 (2004). https:\/\/doi.org\/10.1007\/s00268-003-6903-1","journal-title":"World J. Surg."},{"issue":"2","key":"4431_CR30","doi-asserted-by":"publisher","first-page":"T41","DOI":"10.1530\/ERC-17-0202","volume":"25","author":"A Machens","year":"2018","unstructured":"A. Machens, H. Dralle, Advances in risk-oriented surgery for multiple endocrine neoplasia type 2. Endocr. Relat. Cancer. 25(2), T41\u2013T52 (2018). https:\/\/doi.org\/10.1530\/ERC-17-0202","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"4431_CR31","doi-asserted-by":"publisher","first-page":"L63","DOI":"10.1530\/ERC-17-0189","volume":"24","author":"F Castinetti","year":"2017","unstructured":"F. Castinetti, A.L. Maia, M. Peczkowska, M. Barontini, K. Hasse-Lazar, T.P. Links, R.A. Toledo, S. Dvorakova, C. Mian, M.J. Bugalho, S. Zovato, M. Alevizaki, A. Kvachenyuk, B. Bausch, P. Loli, S.R. Bergmann, A. Patocs, M. Pfeifer, J.B. Costa, von E. Dobschuetz, C. Letizia, G. Valk, M. Barczynski, M. Czetwertynska, J.T.M. Plukker, P. Sartorato, T. Zelinka, P. Vlcek, S. Yaremchuk, G. Weryha, L. Canu, N. Wohllk, F. Sebag, M.K. Walz, C. Eng, H.P.H. Neumann, The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations. Endocr. Relat. Cancer. 24(8), L63\u2013L67 (2017). https:\/\/doi.org\/10.1530\/ERC-17-0189","journal-title":"Endocr. Relat. Cancer"},{"issue":"9","key":"4431_CR32","doi-asserted-by":"publisher","first-page":"L49","DOI":"10.1530\/ERC-17-0349","volume":"25","author":"RM Maciel","year":"2018","unstructured":"R.M. Maciel, L.V. Bim, J.M. Cerutti, Penetrance of pheochromocytoma in RET G533C carriers differs between South America and Europe. Endocr. Relat. Cancer. 25(9), L49\u2013L51 (2018). https:\/\/doi.org\/10.1530\/ERC-17-0349","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"4431_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cen.13386","volume":"87","author":"L Mucha","year":"2017","unstructured":"L. Mucha, G. Leidig-Bruckner, K. Frank-Raue, T. Bruckner, M. Kroiss, F. Raue, German study group for rare thyroid cancer. Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades. Clin. Endocrinol. (Oxf). 87(4), 320\u2013326 (2017). https:\/\/doi.org\/10.1111\/cen.13386","journal-title":"Clin. Endocrinol. (Oxf)"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04431-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:08:19Z","timestamp":1761736099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04431-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4431"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04431-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}